Common Contracts
9 similar Underwriting Agreement contracts by Albemarle Corp, Synnex Corp, Alaris Medical Systems Inc, others
•] Shares of Common Stock SYNNEX CORPORATION UNDERWRITING AGREEMENT November [•], 2005Underwriting Agreement • November 17th, 2005 • Synnex Corp • Services-computer integrated systems design • New York
The stockholders named in Schedule I hereto (the “Selling Stockholders”) of SYNNEX Corporation, a corporation organized and existing under the laws of Delaware (the “Company”), subject to the terms and conditions stated herein, propose severally to sell to the several underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of [•] shares (the “Firm Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). For the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters and subject to the terms and conditions stated herein, a Selling Stockholder also propose to sell to the Underwriters up to [•] additional shares of Common Stock (the “Additional Shares”). Each Selling Stockholder that proposes to sell such Additional Shares to the Underwriters is referred to herein as an “Additional Selling Stockholder”. The Firm Shares and any Additional Shares purchased by the Underwriter
•] Shares of Common Stock SYNNEX CORPORATION UNDERWRITING AGREEMENT November [•], 2005Underwriting Agreement • November 3rd, 2005 • Synnex Corp • Services-computer integrated systems design • New York
The stockholders named in Schedule I hereto (the “Selling Stockholders”) of SYNNEX Corporation, a corporation organized and existing under the laws of Delaware (the “Company”), subject to the terms and conditions stated herein, propose severally to sell to the several underwriters named in Schedule II hereto (the “Underwriters”) an aggregate of [•] shares (the “Firm Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). For the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters and subject to the terms and conditions stated herein, a Selling Stockholder also propose to sell to the Underwriters up to [•] additional shares of Common Stock (the “Additional Shares”). Each Selling Stockholder that proposes to sell such Additional Shares to the Underwriters is referred to herein as an “Additional Selling Stockholder”. The Firm Shares and any Additional Shares purchased by the Underwriter
3,400,000 Shares of Common Stock GOODRICH PETROLEUM CORPORATION UNDERWRITING AGREEMENT May 10, 2005Underwriting Agreement • May 13th, 2005 • Goodrich Petroleum Corp • Crude petroleum & natural gas • New York
BEAR, STEARNS & CO. INC. As Representative of the several Underwriters named in Schedule I attached hereto (the “Representative”)
4,000,000 Shares of Common Stock ALBEMARLE CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • January 20th, 2005 • Albemarle Corp • Plastic materials, synth resins & nonvulcan elastomers • New York
Albemarle Corporation, a corporation organized and existing under the laws of the Commonwealth of Virginia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 4,000,000 shares (the “Company Shares”) of its common stock, par value $.01 per share (the “Common Stock”). The shareholders of the Company listed on Schedule II hereto (the “Selling Shareholders”) severally propose to sell to the Underwriters an aggregate of 488,420 shares of Common Stock (the “Selling Shareholders’ Shares” and together with the Company Shares, the “Firm Shares”). For the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, the Company also proposes to issue and sell to the Underwriters up to an additional 673,000 shares of Common Stock (the “Additional Shares”). The Firm Shares and any Additional Shares
Shares of Common Stock ALBEMARLE CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2004 • Albemarle Corp • Plastic materials, synth resins & nonvulcan elastomers • New York
Albemarle Corporation, a corporation organized and existing under the laws of the Commonwealth of Virginia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of shares (the “Company Shares”) of its common stock, par value $.01 per share (the “Common Stock”). The shareholders of the Company listed on Schedule II hereto (the “Selling Shareholders”) severally propose to sell to the Underwriters an aggregate of shares of Common Stock (the “Selling Shareholders’ Shares” and together with the Company Shares, the “Firm Shares”). For the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, the Company also proposes to issue and sell to the Underwriters up to an additional shares of Common Stock (the “Additional Shares”). The Firm Shares and any Additional Shares purchased by the Underwriters
IMMUNOMEDICS, INC. FORM OF UNDERWRITING AGREEMENT [DATE]Underwriting Agreement • April 23rd, 2004 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Immunomedics, Inc., a corporation organized and existing under the laws of Delaware (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) [ ] shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), (b) [ ] shares of the Company’s preferred stock, par value $0.01 per share (the “Preferred Stock”), (c) [ ] depositary shares evidencing interests in a share or shares of Preferred Stock (“Depositary Shares”), (d) [ ] warrants to purchase Common Stock (“Common Stock Warrants”), or (e) [ ] warrants to purchase Preferred Stock (“Preferred Stock Warrants”), or any combination of such shares of Common Stock, shares of Preferred Stock, Depositary Shares, Common Stock Warrants and Preferred Stock Warrants (such securities or combination of securities to be sold to the Underwriters, the “Securities”). The Securities are more fully de
Shares of Common Stock SYNNEX CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • October 14th, 2003 • Synnex Information Technologies Inc • Services-computer integrated systems design • New York
9,100,000 Shares of Common Stock ALARIS Medical Inc. UNDERWRITING AGREEMENT June 25, 2003Underwriting Agreement • July 14th, 2003 • Alaris Medical Systems Inc • Surgical & medical instruments & apparatus • New York
BEAR, STEARNS & CO. INC. CITIGROUP GLOBAL MARKETS INC. UBS SECURITIES LLC As Representatives of the several Underwriters named in Schedule I attached hereto c/o Bear, Stearns & Co. Inc. 383 Madison Avenue New York, New York 10179
3,000,000 Shares of Common Stock VIASYS HEALTHCARE INC. UNDERWRITING AGREEMENT As of June 17, 2003Underwriting Agreement • June 19th, 2003 • Viasys Healthcare Inc • Wholesale-medical, dental & hospital equipment & supplies • New York
VIASYS Healthcare Inc., a corporation organized and existing under the laws of Delaware (the "Company"), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (the "Underwriters") an aggregate of 3,000,000 shares (the "Firm Shares") of its common stock, par value $0.01 per share (the "Common Stock") and, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, up to an additional 450,000 shares (the "Additional Shares") of Common Stock. The Firm Shares and any Additional Shares purchased by the Underwriters are referred to herein as the "Shares". The Shares are more fully described in the Registration Statement and Prospectus referred to below. Bear, Stearns & Co. Inc. ("Bear Stearns") and J.P. Morgan Securities Inc. ("JPMorgan") are acting as co-lead managers (the "Lead Managers") in connection with the offering and sale of the Shar
